Oncogene Concatenated Enriched Amplicon Nanopore Sequencing for rapid, accurate, and affordable somatic mutation detection

Genome Biol. 2021 Sep 6;22(1):227. doi: 10.1186/s13059-021-02449-1.

Abstract

We develop the Oncogene Concatenated Enriched Amplicon Nanopore Sequencing (OCEANS) method, in which variants with low variant allele frequency (VAFs) are amplified and subsequently concatenated for Nanopore Sequencing. OCEANS allows accurate detection of somatic mutations with VAF limits of detection between 0.05 and 1%. We construct 4 distinct multi-gene OCEANS panels targeting recurrent mutations in acute myeloid leukemia, melanoma, non-small- cell lung cancer, and hepatocellular carcinoma and validate them on clinical samples. By demonstrating detection of low VAF single nucleotide variant mutations using Nanopore Sequencing, OCEANS is poised to enable same-day clinical sequencing panels.

Keywords: Cancer; Mutation detection; Nanopore Sequencing.

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / genetics
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Leukemia, Myeloid, Acute / genetics
  • Lung Neoplasms / genetics
  • Melanoma
  • Mutation*
  • Nanopore Sequencing / methods*
  • Neoplasms / genetics*
  • Oncogenes / genetics*